One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides
Authors:
- Shivanand O. RichardsonSRShivanand O. Richardson
- Manon M. H. HuibersMHManon M. H. Huibers
- Roel A. de WegerRWRoel A. de Weger
- Wendy W. J. de LengWLWendy W. J. de Leng
- John W. J. HinrichsJHJohn W. J. Hinrichs
- Ruud W. J. MeijersRMRuud W. J. Meijers
- Stefan M. WillemsSWStefan M. Willems
- Ton L. M. G. PeetersTPTon L. M. G. Peeters
Open Access
- 17 June 2019
- journal article
- research article
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 12 (1) , 1-10
Abstract
The Fluorescence In Situ Hybridization (FISH) technique is a very useful tool for diagnostic and prognostic purposes in molecular pathology. However, clinical testing on patient tissue is challenging due to variables of tissue processing that can influence the quality of the results. This emphasizes the necessity of a standardized FISH protocol with a high hybridization efficiency. We present a pretreatment protocol that is easy, reproducible, cost-effective, and facilitates FISH on all types of patient material simultaneously with good quality results. During validation, FISH analysis was performed simultaneously on formalin-fixed paraffin-embedded, fresh frozen and cytological patient material in combination with commercial probes using our optimized one-fits-all pretreatment protocol. An optimally processed sample is characterized by strong specific signals, intact nuclear membranes, non-disturbing autofluorescence and a homogeneous DAPI staining. In our retrospective cohort of 3881 patient samples, overall 93% of the FISH samples displayed good quality results leading to a patient diagnosis. All FISH were assessed on quality aspects such as adequacy and consistency of signal strength (brightness), lack of background and / or cross-hybridization signals, and additionally the presence of appropriate control signals were evaluated to assure probe accuracy. In our analysis 38 different FISH probes from 3 commercial manufacturers were used (Cytocell, Vysis and ZytoLight). The majority of the patients in this cohort displayed good signal quality and barely non-specific background fluorescence on all tissue types independent of which commercial probe was used. The optimized one-fits-all FISH method is robust, reliable and reproducible to deliver an accurate result for patient diagnostics in a lean workflow and cost-effective manner. This protocol can be used for widespread application in cancer and non-cancer diagnostics and research.Keywords
Funding Information
- Universitair Medisch Centrum Utrecht (Not applicable)
This publication has 16 references indexed in Scilit:
- Validation of break-apart and fusion MYC probes using a digital fluorescence in situhybridization capture and imaging systemJournal of Pathology Informatics, 2016
- Comparison of the Cellient™ automated cell block system and agar cell block methodCytopathology, 2014
- Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicineBiomarker Research, 2014
- Fluorescence In Situ HybridizationJournal of Investigative Dermatology, 2013
- Validation of Fluorescence In Situ Hybridization Using an Analyte-Specific Reagent for Detection of Abnormalities Involving the Mixed Lineage Leukemia GeneArchives of Pathology & Laboratory Medicine, 2012
- Fluorescence In Situ Hybridization Analysis of Formalin Fixed Paraffin Embedded Tissues, Including Tissue Microarrays2010
- Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significanceBioscience Horizons, 2010
- Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasmsLaboratory Investigation, 2008
- Effect of Fixatives and Tissue Processing on the Content and Integrity of Nucleic AcidsThe American Journal of Pathology, 2002
- Fluorescence In Situ Hybridization in Paraffin Tissue SectionsMolecular Biotechnology, 2002